March 12, 2018 / 1:11 PM / 2 months ago

BRIEF-Exalenz Q4 Revenue Up 161 Pct

March 12 (Reuters) - Exalenz Bioscience Ltd:

* EXALENZ ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

* SEES FY 2018 SALES $17 MILLION TO $19 MILLION

* Q4 REVENUE ROSE 161 PERCENT TO $3.0 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below